The small increased risk of gallbladder problems with Wegovy (2.5% vs 1% with placebo) should be viewed in context
In 2023, the FDA launched an investigation after GLP-1 agonist users started reporting thoughts of suicide as of January 2024, it hadnt found anything to confirm the connection, but it also said it couldnt yet rule it out, meaning its possible the drugs could cause mental health issues for some people, rather than treating or preventing them
Some studies show no significant improvement in eating disorder behaviors, and experts warn that these medications could potentially worsen disordered eating patterns in vulnerable populations
A nutrient-rich breakfast fuels your body and may also help you manage unwanted side effects, such as nausea or constipation
We change treatment plans based on lab results and how youre feeling
NICE recommends this for adults with a BMI of 40 kg/m or above, or 35 kg/m with significant comorbidities